0001054102 2026-08-20 2026-08-20 true 0001054102 8-K/A 2026-08-20 INTERPACE BIOSCIENCES, INC. DE 000-24249 22-2919486 Waterview Plaza Suite 310 2001 Route 46 Parsippany NJ 07054 (855) 776-6419 false false false false false As previously disclosed in the Current Report on Form 8-K (the “Initial Report”) filed with the Securities and Exchange Commission (the “SEC”) on August 20, 2026, Interpace Biosciences, Inc. (the “Company”) held its annual meeting of stockholders during which stockholders approved the 2026 Benefit Plans (as defined below). This Amendment No. 1 on Form 8-K/A is being filed by the Company to amend the Initial Report, solely to disclose the adoption of the 2026 Benefit Plans. Except as otherwise provided herein, the disclosures made in the Initial Report remain unchanged. As such, this Amendment No. 1 should be read in conjunction with the Initial Report.